Diabetic nephropathy is the most common cause of end-stage renal disease (ESRD), and the proportion of patients with ESRD who have diabetes (most of whom have T2DM) has increased over the past ...
Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...
As part of its ongoing RAK diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the LINK between diabetes and kidney disease, shedding light on the prevention ...
ASCEND was a multicenter, placebo-controlled trial that aimed to investigate the effects of the endothelin-A (ET A) receptor antagonist avosentan in patients with diabetic nephropathy.The study ...
The basis for the prevention of diabetic nephropathy is the treatment of its known risk factors: hypertension, hyperglycemia, smoking, and dyslipidemia. These are also risk factors for ...
All diabetics are prone to kidney damage. However, the chances of developing diabetic nephropathy depends on a number of factors. Some diabetics may suffer from kidney damage right at the time of ...
Diabetic nephropathy stands as the most common contributor to the onset of chronic kidney disease (CKD) and end-stage renal disease on a global scale. The same applies to India, where the prevalence ...
Diabetes, a progressive disease that affects most of your body parts, including your kidneys, can cause nephropathy - the symptoms of which do not appear until later stages, but they include swelling, ...
Losartan is a generic oral tablet used to treat high blood pressure and related conditions. Find out what the recommended dosages are, how to take the drug, and more.